Sign in / Join Now
ETFs & Funds
The money for
with reasZin is in macular degeneration and preventing infections in the elderly.
Add a reply...
Latest StockTalks »
people get SYN breaking news and analysis by email alert.
Get email alerts on SYN »
Synthetic Biologics, Inc.
Get latest price
From other sites
Synthetic Biologics Confirms Key Features Of Pivotal Phase 2b/3 Trial Of SYN-010 Pursuant To Consultations With FDA
at TheStreet (Wed, 4:09PM)
Synthetic Biologics' SYN-004 (ribaxamase) Achieves Primary Endpoint In Phase 2b Trial For C. Difficile Infection (CDI)
at TheStreet (Jan 5, 2017)
Synthetic Biologics To Present At The Biotech Showcase™ 2017 Conference
at TheStreet (Jan 3, 2017)
Synthetic Biologics Announces Granting Of U.S. Composition Of Matter Patent For SYN-005, Designed For The Treatment And Prevention Of Pertussis (Whooping Cough)
at TheStreet (Dec 13, 2016)
Synthetic Biologics Announces Participation In Two Upcoming Investor Conferences
at TheStreet (Dec 1, 2016)